Colombia expands HIV medication access

AI executive summary
The story at a glance, best enjoyed with a coffee ☕
Colombia's Ministry of Health removed restrictions for access to the antiretroviral DLT, allowing any person with HIV affiliated with the health system to receive this treatment according to medical criteria. The decision, established in External Circular 033 of October 21, 2026 and disseminated on November 9, expands coverage that was previously limited to specific groups such as recently diagnosed Venezuelan migrants or with virological failure. The medication combines three active ingredients to control virus replication, allowing to achieve undetectable viral loads when taken constantly, which also prevents its sexual transmission according to the principle 'undetectable equals untransmissible'.
🔔 Sign in to follow this story and get its updates.
In this story you will find
AI analysis
Why it matters
This measure directly benefits all people with HIV affiliated with the health system, guaranteeing access to an effective treatment without population barriers. It also contributes to reducing stigma and promotes the principle 'undetectable equals untransmissible', key to preventing virus transmission.
▸▾ Rate, add sources or report this story
Sign in to rate this story and add sources.
Community annexes
Coverage of this same story by other outlets, contributed by readers and checked automatically.
Ask about this coverage
Get an AI answer grounded in reports from different outlets, with links to the sources.